UKDRI
UK DRI at Cardiff
Hadyn Ellis building

UK DRI at Cardiff

Paul Morgan

Prof Paul Morgan

Interim Centre Director

Investigating exactly how key immune proteins contribute to Alzheimer's disease development

Prof Paul Morgan

At the UK DRI at Cardiff, we're exploring the function of genes involved in Alzheimer’s, Parkinson’s and Huntington’s disease. We will use this knowledge to identify new molecular targets that can lead us to discover new drugs to prevent or treat dementia.

Cardiff University logo

Contact

Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ
Tina Cottrell

The UK DRI at Cardiff is the biggest investment Wales has made in neurodegenerative disease research to date. The Centre brings together scientists from a range of research backgrounds, with expertise in genetics, immunology, computational analytics, synaptic function and DNA repair. 

The highly collaborative team bring fresh ideas and perspectives, and are working together to discover new disease mechanisms, identify drug targets, and ultimately deliver new treatments for Alzheimer’s, Parkinson’s, Huntington’s and other neurodegenerative diseases. 

Latest news

All news

People

Type
Dayne Beccano-Kelly

Dr Dayne Beccano-Kelly

Group Leader

UK DRI at Cardiff

Investigating synaptic health and function over time in Parkinson's

Learn more Dr Dayne Beccano-Kelly
Vincent Dion

Prof Vincent Dion

Group Leader

UK DRI at Cardiff

Developing new treatments to stop the progression of expanded repeat disorders

Learn more Prof Vincent Dion
Valentina Escott-Price

Prof Valentina Escott-Price

Group Leader

UK DRI at Cardiff

Using Big Data, machine learning and AI to accelerate discoveries into dementia

Learn more Prof Valentina Escott-Price
Tom Massey

Dr Tom Massey

Group Leader

UK DRI at Cardiff

Using recent genetic discoveries to develop new drug targets for Huntington's disease

Learn more Dr Tom Massey
Paul Morgan

Prof Paul Morgan

Interim Centre Director

UK DRI at Cardiff

Investigating exactly how key immune proteins contribute to Alzheimer's disease development

Learn more Prof Paul Morgan
Phil Taylor

Prof Phil Taylor

Group Leader

UK DRI at Cardiff

Working to understand how rare coding variants that alter disease risk impact the behaviour of microglia for targeting in Alzheimer's disease

Learn more Prof Phil Taylor
Caleb Webber

Prof Caleb Webber

Director of Data Science & Group Leader

UK DRI at Cardiff

Combining state-of-the-art stem cell models with bioinformatics techniques to boost our understanding of the biological mechanisms underlying Parkinson’s disease

Learn more Prof Caleb Webber
Julie Williams

Prof Julie Williams

Group Leader

UK DRI at Cardiff

Understanding the genetics of Alzheimer's disease

Learn more Prof Julie Williams

Scientific focus

Read about the scientific focus of the UK DRI at Cardiff

Research at the UK DRI at Cardiff
Neurons and microglia